← Back to NAUT

Nautilus Biotechnology, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSMar 2026Filed 28/04/2026Sep 2025Filed 28/10/2025Jun 2025Filed 31/07/2025Mar 2025Filed 28/04/2026Sep 2024Filed 28/10/2025Jun 2024Filed 31/07/2025Mar 2024Filed 29/04/2025Sep 2023Filed 29/10/2024
−$15−$14−$15−$17−$16−$18−$19−$16
−$0.12−$0.11−$0.12−$0.13−$0.13−$0.14−$0.15−$0.13
127126126126125125125125

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.